Both in Pharmaceuticals
Arrowhead Research vs Praxis Precision Medicines
Over the past year ARWR returned +51.9% and PRAX returned +56.0%; their daily moves had a correlation of 0.22.
ARWR +51.9% PRAX +56.0%Growth of $1, one year, split-adjusted
| Metric | ARWR | PRAX |
|---|---|---|
| Price | $60.15 | $283.89 |
| Market cap | $8.50B | $7.93B |
| Today | +0.97% | +3.61% |
| 1 month | −3.5% | +0.1% |
| 6 months | −19.7% | −14.8% |
| Year to date | −9.4% | −3.7% |
| 1 year | +41.9% | +42.8% |
| Revenue growth (YoY) | +171.0% | — |
| Gross margin | 100.0% | — |
| Net margin | −258.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 12.7× | — |
| Net cash | $737.9M | $758.6M |
| Dividend yield | — | — |
| Volatility (60d) | 45.2% | 48.8% |
| Short % of float | 8.1% | 14.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).